跳至主要内容
临床试验/ACTRN12613000110785
ACTRN12613000110785尚未招募不适用

Evaluating the improvement in reproducibility of respiratory-related tumour motion (via fiducial maker surrogacy) for 30 liver cancer patients by assessing the potential clinical benefit of the audiovisual (AV) biofeedback respiratory guidance system.

niversity of Sydney0 个研究点目标入组 30 人开始时间: 2013年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1) Liver cancer patients, either primary hepatocellular carcinoma or liver metastases, eligible for stereotactic radiotherapy
  • 2)> 18 years old
  • 3)No gender or ethnic restrictions
  • 4)Radio-opaque markers implanted (fiducials and/or surgical clips previously implanted in the liver)
  • 5)Ability to give written informed consent and willingness to participate and comply with the study

排除标准

  • 1)Pregnant/ lactating women
  • 2)<18 years old.
  • 3)Prior radiotherapy treatment to the liver
  • 4)Life expectancy less than 6 months
  • 5)Non-liver cancer patients

研究者

相似试验